My research is focused on P. falciparum malaria, including the efficacy and safety of antimalarial drugs, methods to improve quality of care and fever case management, surveillance of malaria-related morbidity and mortality, and novel approaches to prevent and control malaria. 

I am particularly interested in intermittent preventive treatment (IPT) of malaria in schoolchildren and the role of chemoprevention in malaria control. We recently completed the START-IPT trial (School-based treatment with ACT to reduce transmission of malaria) in Jinja, Uganda. This cluster-randomised trial assessed the impact of IPT for malaria in schoolchildren with dihydroartemisinin-piperaquine (DP) on population-level outcomes and malaria transmission in Uganda.

My current research projects include:

Uganda PBO Net Study: Impact of long-lasting insecticide treated bednets (LLINs) with and without piperonyl butoxide (PBO) on malaria indicators in Uganda; funded by the Against Malaria Foundation (Dec 2016 to Dec 2018). This cluster-randomised trial aims to evaluate the impact of LLINs distributed in a national campaign in 48 districts in Uganda.

Program for Resistance, Immunology, Surveillance and Modelling of Malaria in Uganda (PRISM2), funded by the US National Institutes of Health (July 2017 to June 2024). A cohort study of community residents living in Tororo, Uganda will provide the framework for research on the epidemiology and transmission of malaria, and parasite and insecticide resistance.

Anti-Microbials In Society: A Global Interdisciplinary Research Hub (AMIS Hub); funded by the UK’s Economic and Social Research Council (May 2017 to April 2021). This qualitative project will investigate use of antimicrobials (anti-malarial drugs and antibiotics) including how drugs are used in human health care, agriculture, farming, and factories.